Case Study

Scaling From Cell Factory™ Systems To An iCELLis® 500 Bioreactor Without Affecting Critical Quality Attributes

GettyImages-675822742-cleanroom-bioreactor

The challenge was to identify an effective, replicable, and large-scale lentiviral vector (LVV) manufacturing process, evolving from the well-established GMP 48L Nunc™ Cell Factory™ (CF) process, to meet the growing manufacturing demand – especially for market application – without affecting critical quality attributes.

Following rigorous testing, a robust, scalable, high quality and quantity process was developed for the industrial scale production of LVV for use in gene-modified cell therapy or in vivo gene therapy. Explore the details and data of the process.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: